GB1398722A - Disbustistuted xanthone carboxylic acid compounds - Google Patents
Disbustistuted xanthone carboxylic acid compoundsInfo
- Publication number
- GB1398722A GB1398722A GB3253472A GB3253472A GB1398722A GB 1398722 A GB1398722 A GB 1398722A GB 3253472 A GB3253472 A GB 3253472A GB 3253472 A GB3253472 A GB 3253472A GB 1398722 A GB1398722 A GB 1398722A
- Authority
- GB
- United Kingdom
- Prior art keywords
- alkyl
- cycloalkyl
- alkoxy
- product
- xanthone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
- C07D311/82—Xanthenes
- C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
- C07D311/86—Oxygen atoms, e.g. xanthones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pulmonology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
1398722 Disubstituted xanthone carboxylic acid compounds SYNTEX (USA) Inc 12 July 1972 [12 Jan 1972 5 June 1972] 32534/72 Heading C2C The invention comprises compounds of the formula and non-toxic esters, amides, and salts thereof; wherein, either the X groups are identical and selected from 1-hydroxy-(C 1 -C 5 ) alkyl and the (C 1 -C 5 ) alkyl, cycloalkyl, tetrahydrofuran-2-yl, tetrahydropyran - 2 - yl, tetrahydropyran - 4- yl and 4 - alkoxytetrahydropyran - 4 - yl ethers thereof and the carboxylic acyl esters thereof; and lower alkanoyl; or one X group is selected from (C 1 -C 5 ) alkyl, cycloalkyl, (C 1 - C 5 ) alkoxy and cycloalkoxy, and the other X group is selected from 1-hydroxy (C 1 -C 5 ) alkyl and the (C 1 -C 5 ) alkyl, cycloalkyl, tetrahydrofuran - 2 - yl, tetrahydropyran - 2 - yl, tetrahydropyran - 4 - yl and 4 - alkoxytetrahydropyran-4-yl ethers thereof and the carboxylic acyl esters thereof; and lower alkanoyl. They may be obtained by (1) oxidizing a 5,7-dialkylxanthone-2-carboxylic acid with chromic oxide in acetic acid-acetic anhydride to give the corresponding 5,7-dialkanoylxanthone-2-carboxylic acids; and (2) optionally reducing a product of step (1) to give the corresponding 5,7-bis-(1- hydroxyalkyl)-xanthone-2- carboxylic acids; or (3) acylating a 5- or 7-alkyl-, cycloalkyl-, alkoxy- or cycloalkoxy-xanthene-2-carboxylic acid alkyl ester with alkanoyl chloride, oxidizing the acylated products, to those corresponding in the xanthone series, optionally followed by hydrolysis to give the corresponding 5- alkyl-, cycloalkyl-, alkoxy- or cycloalkoxy-7- alkanoylxanthone - 2 - carboxylic acids or the alkyl esters thereof and 5-alkanoyl-7-alkyl-, cycloalkyl-, alkoxy- or cycloalkoxy xanthone- 2-carboxylic acids or the alkyl esters thereof; and (4) optionally reducing an acylated product in the xanthene series of step (3) to give the corresponding 5-alkyl-, cycloalkyl-, alkoxy- or cycloalkoxy - 7 - (1 - hydroxymethyl) - xanthene - 2 - carboxylic acid alkyl esters and the corresponding 5 - (1 - hydroxymethyl) - 7- alkylcycloalkyl-, alkoxy- or cycloalkoxyxanthene - 2 - carboxylic acid alkyl esters, acylating the latter, oxidizing the acylated product, and basc hydrolysing the oxidized products to give the corresponding 5-alkyl-, cycloalkyl, alkoxy- or cycloalkoxy-7-(1-hydroxymethyl) - xanthone - 2 - carboxylic acids and 5 - (1 - hydroxyalkyl) - 7 - alkyl-, cycloalkyl-, alkoxy- or cycloalkoxy - xanthone - 2 - carboxylic acids; and (5) optionally esterifying a hydroxyalkyl product of steps (2) and (4) to give the corresponding acyloxyalkylxanthone-2-carboxylic acid; and (6) optionally etherifying a hydroxyalkyl product of steps (2) and (4) to give the corresponding etherified hydroxyalkylxanthone-2-carboxylic acid; and (7) optionally converting a product of steps (1), (2), (3), (4), (5) and (6) to a corresponding pharmaceutically acceptable, non-toxic ester, amide or salt. Examples are aiven for the production of the compounds. Pharmaceutical compositions comprise the compounds of the above formula which may be administered orally, topically, parenterally or by inhalation in conventional forms optionally together with other pharmaceutical agents. They are useful for inhibiting the effects of allergic reactions, also as smooth muscle relaxants and as vasodilators. The 5,7 - dialkyl - xanthone - 2 - carboxylic acids are prepared by condensing o,p-dialkylphenol with a 1,3-dicarboalkoxy-4-halobenzene, base hydrolysing the product thereof, and cyclizing the hydrolysed product. The starting compounds of step (3) are prepared by reducing a 5- or 7-alkyl-, cycloalkyl-, alkoxy- or cycloalkoxy xanthone - 2 - carboxylic acid and esterifying the product thereof, said 5- or 7-alkyl-, cycloalkyl-, alkoxy- or cycloalkoxy-xanthone-2-carboxylic acid being optionally prepared by condensing a o- or p-alkyl-, cycloalkyl-, alkoxy- or cycloalkoxyphenol with a 1,3-dicarboalkoxy-4-halobenzene, base hydrolysing the product, and cyclizing the hydrolysed product.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US00217287A US3849565A (en) | 1972-01-12 | 1972-01-12 | Disubstituted xanthone carboxylic acid compounds for inhibiting asthma |
US25985272A | 1972-06-05 | 1972-06-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1398722A true GB1398722A (en) | 1975-06-25 |
Family
ID=26911795
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB4736974A Expired GB1398723A (en) | 1972-01-12 | 1972-07-12 | Chlorosulphonyl-xanthone-2-carboxylic acids |
GB4737574A Expired GB1398725A (en) | 1972-01-12 | 1972-07-12 | Disubstituted xanthone carboxylic acid compounds |
GB3253472A Expired GB1398722A (en) | 1972-01-12 | 1972-07-12 | Disbustistuted xanthone carboxylic acid compounds |
GB4737374A Expired GB1398724A (en) | 1972-01-12 | 1972-07-12 | Disubstituted xanthone carboxylic acid compounds |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB4736974A Expired GB1398723A (en) | 1972-01-12 | 1972-07-12 | Chlorosulphonyl-xanthone-2-carboxylic acids |
GB4737574A Expired GB1398725A (en) | 1972-01-12 | 1972-07-12 | Disubstituted xanthone carboxylic acid compounds |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB4737374A Expired GB1398724A (en) | 1972-01-12 | 1972-07-12 | Disubstituted xanthone carboxylic acid compounds |
Country Status (15)
Country | Link |
---|---|
JP (4) | JPS5347107B2 (en) |
AR (5) | AR202889A1 (en) |
AT (2) | AT327897B (en) |
AU (1) | AU465362B2 (en) |
BE (1) | BE793749A (en) |
CA (1) | CA1014167A (en) |
CH (4) | CH586694A5 (en) |
DE (1) | DE2265054A1 (en) |
ES (6) | ES404790A1 (en) |
FR (1) | FR2167490B1 (en) |
GB (4) | GB1398723A (en) |
IL (1) | IL39891A (en) |
NL (1) | NL7209629A (en) |
NO (3) | NO137199C (en) |
SE (1) | SE387946B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE1010719A3 (en) | 1996-10-28 | 1998-12-01 | Dsm Nv | Process for the preparation of hydroxylammonium. |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE759292A (en) * | 1969-11-27 | 1971-05-24 | Allen & Hanburys Ltd | XANTHONE DERIVATIVES, THEIR PREPARATION AND THEIR USE |
-
0
- BE BE793749D patent/BE793749A/en unknown
-
1972
- 1972-07-12 SE SE7209197A patent/SE387946B/en unknown
- 1972-07-12 CH CH1177576A patent/CH586694A5/xx not_active IP Right Cessation
- 1972-07-12 CH CH1177376A patent/CH586692A5/xx not_active IP Right Cessation
- 1972-07-12 FR FR7225352A patent/FR2167490B1/fr not_active Expired
- 1972-07-12 GB GB4736974A patent/GB1398723A/en not_active Expired
- 1972-07-12 CH CH1045772A patent/CH588483A5/xx not_active IP Right Cessation
- 1972-07-12 AT AT860574*7A patent/AT327897B/en not_active IP Right Cessation
- 1972-07-12 NL NL7209629A patent/NL7209629A/xx not_active Application Discontinuation
- 1972-07-12 AR AR243026A patent/AR202889A1/en active
- 1972-07-12 GB GB4737574A patent/GB1398725A/en not_active Expired
- 1972-07-12 GB GB3253472A patent/GB1398722A/en not_active Expired
- 1972-07-12 CH CH1177476A patent/CH586693A5/xx not_active IP Right Cessation
- 1972-07-12 AT AT860674*7A patent/AT327898B/en not_active IP Right Cessation
- 1972-07-12 JP JP6985272A patent/JPS5347107B2/ja not_active Expired
- 1972-07-12 NO NO2495/72A patent/NO137199C/en unknown
- 1972-07-12 GB GB4737374A patent/GB1398724A/en not_active Expired
- 1972-07-12 IL IL39891A patent/IL39891A/en unknown
- 1972-07-12 AU AU44458/72A patent/AU465362B2/en not_active Expired
- 1972-07-12 DE DE19722265054 patent/DE2265054A1/en active Pending
- 1972-07-12 ES ES404790A patent/ES404790A1/en not_active Expired
-
1973
- 1973-01-01 AR AR249068A patent/AR208274A1/en active
- 1973-03-19 NO NO1092/73A patent/NO137204C/en unknown
- 1973-03-19 NO NO1091/73A patent/NO137203C/en unknown
- 1973-07-13 AR AR249071A patent/AR202188A1/en active
-
1974
- 1974-11-14 CA CA213,708A patent/CA1014167A/en not_active Expired
-
1975
- 1975-01-01 AR AR259804A patent/AR206878A1/en active
- 1975-01-01 AR AR258182A patent/AR206919A1/en active
- 1975-01-03 ES ES433555A patent/ES433555A1/en not_active Expired
- 1975-01-03 ES ES433552A patent/ES433552A1/en not_active Expired
- 1975-01-03 ES ES433554A patent/ES433554A1/en not_active Expired
- 1975-01-03 ES ES433553A patent/ES433553A1/en not_active Expired
- 1975-02-26 ES ES435108A patent/ES435108A1/en not_active Expired
-
1977
- 1977-06-01 JP JP6457077A patent/JPS5350170A/en active Pending
- 1977-06-01 JP JP6457177A patent/JPS5350171A/en active Pending
- 1977-06-01 JP JP6457277A patent/JPS5350172A/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1305793A (en) | ||
GB1304175A (en) | ||
GB1369543A (en) | Indenylalkanoic acid compounds | |
GB1470468A (en) | Hydro-aromatic compounds | |
GB1417103A (en) | Furoyl-acetic acid derivatives | |
GB1398722A (en) | Disbustistuted xanthone carboxylic acid compounds | |
ES433550A1 (en) | Disubstituted xanthone carboxylic acid compounds for inhibiting asthma | |
GB1395666A (en) | Thiophene derivatives processes for their preparation and compositions incorporating them | |
GB1424416A (en) | Prostaglandin intermediates and their preparation | |
GB1153670A (en) | Isoquinoline Derivatives and preparation thereof | |
GB1386436A (en) | Xanthone carboxylic acids and derivatives | |
IE38659B1 (en) | New pregnane acid derivatives | |
GB1394584A (en) | Heterocyclic substituted xanthone carboxylic acid compounds | |
GB1496307A (en) | Hypolipidemic agents | |
GB1398096A (en) | Substituted xanthone carboxylic acid compounds | |
GB1411700A (en) | Penicillins and production thereof | |
GB1393414A (en) | Heterocyclic substituted xanthone carboxylic acid compounds | |
US2806039A (en) | Steroid intermediates | |
GB1384145A (en) | Disubstituted xanthone carboxylic acid compounds | |
ES435561A1 (en) | Substituted xanthone carboxylic acid compounds | |
GB1394385A (en) | Substituted xanthone carboxylic acid compounds | |
ES435567A1 (en) | Disubstituted xanthone carboxylic acid compounds | |
ES433626A2 (en) | Disubstituted xanthone carboxylic acid compounds | |
GB1446222A (en) | Carboxylic acid derivatives and processes for their manufacture | |
GB1298620A (en) | Substituted benzopyrans and process for the production thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed [section 19, patents act 1949] | ||
PCNP | Patent ceased through non-payment of renewal fee |